Retrospective independent review of arterial occlusive events (AOEs) in the ponatinib phase 2 PACE trial (NCT01207440) in patients with Philadelphia chromosome positive (Ph+) leukemia Meeting Abstract


Authors: Januzzi, J.; Garasic, J.; Kasner, S.; McDonald, V.; Petrie, M.; Seltzer, J.; Mauro, M.; Croce, K.; Berman, E.; Deininger, M.; Hochhaus, A.; Pinilla-Ibarz, J.; Nicolini, F.; Kim, D. W.; DeAngelo, D.; Kantarjian, H.; Xu, J.; Srivastava, S.; Naranjo, D.; Cortes, J.
Abstract Title: Retrospective independent review of arterial occlusive events (AOEs) in the ponatinib phase 2 PACE trial (NCT01207440) in patients with Philadelphia chromosome positive (Ph+) leukemia
Meeting Title: 8th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Keywords: cml; inhibitor; chronic myeloid leukemia; acute lymphoblastic leukemia; safety; tyrosine kinase; adverse event; ponatinib; arterial occlusive event; pace
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 20
Issue: Suppl. 1
Meeting Dates: 2020 Sep 9-12
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2020-09-01
Start Page: S231
End Page: S232
Language: English
ACCESSION: WOS:000564055100183
PROVIDER: wos
DOI: 10.1016/S2152-2650(20)30810-7
Notes: Meeting Abstract: CML-089 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ellin Berman
    173 Berman
  2. Michael John Mauro
    267 Mauro